GNRH ANTAGONIST
Clinical trials for GNRH ANTAGONIST explained in plain language.
Never miss a new study
Get alerted when new GNRH ANTAGONIST trials appear
Sign up with your email to follow new studies for GNRH ANTAGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
IVF breakthrough? new study tests simpler drug protocol for PCOS
Disease control Not yet recruitingThis study aims to find out which of two common medication plans works better for women with PCOS undergoing IVF with genetic testing. Researchers will compare a newer, simpler oral medication plan (PPOS) against a standard injectable plan (GnRH antagonist). The main goal is to s…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE3 • Sponsor: ShangHai Ji Ai Genetics & IVF Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New injection aims to starve prostate cancer
Disease control Not yet recruitingThis study is testing a new injection called Teverelix DP for men with advanced prostate cancer that has spread or cannot be cured. The drug works by quickly lowering testosterone, a hormone that fuels prostate cancer growth. Researchers will give 40 men a series of injections ov…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC